The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Roger Li
Stock and Other Ownership Interests - Beam Therapeutics; CRISPR therapeutics; Intellia Therapeutics; Lilly
Honoraria - IBCG; MashupMD; UroToday
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Ferring; ImmunityBio; Johnson & Johnson/Janssen; Merck; Pfizer; Photocure; Urogen pharma; Valar Labs
Speakers' Bureau - Johnson & Johnson/Janssen
Research Funding - CG Oncology; Predicine; Valar Labs
Travel, Accommodations, Expenses - CG Oncology; Predicine
Other Relationship - Predicine
 
Ashish Kamat
Leadership - American Urological Association; International Bladder Cancer Group (IBCG); World Bladder Cancer Patient Coalition
Consulting or Advisory Role - Aspira Women's Health (I); Astellas Pharma; Atonco Pharma; Biological Dynamics; Bristol-Myers Squibb; CG Oncology; Cystotech; Eisai; enGene; Ferring; Genentech; Imagin Medical; ImmunityBio; Imvax; Incyte; Janssen; Medac; Merck; Nonagen Bioscience; Pfizer; Photocure; Protara Therapeutics; Roche; Seagen; Sesen Bio; Theralase; Urogen pharma; US Biotest; Valar Labs; Vivet Therapeutics
Research Funding - Arquer Diagnostics (Inst); enGene (Inst); FKD Therapies (Inst); Patient-Centered Outcomes Research Institute (PCORI) (Inst); Photocure (Inst); Seagen (Inst); SWOG (Inst)
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - European Urology Oncology; Journal of Urology; UroToday
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Catalym; Genenta Science; Gilead Sciences; Incyte; Johnson & Johnson/Janssen; Merck Serono; Merck Sharp & Dohme; Peerview; PeerVoice; Samsung Bioepis; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Gilead Sciences (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Janssen; Merck Sharp & Dohme
 
Joydeep Banerjee
Employment - Moderna Therapeutics
Stock and Other Ownership Interests - Moderna Therapeutics
Travel, Accommodations, Expenses - Moderna Therapeutics
 
Sarah Keidel
No Relationships to Disclose
 
David Huang
No Relationships to Disclose
 
Nancy Davis
Employment - Merck, Sharp & Dohme, Inc
 
Petros Grivas
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; Foundation Medicine; Gilead Sciences; Janssen; Lilly; Merck; Pfizer; Replimune; Roche; Strata Oncology; Tyra Biosciences; Urogen pharma
Research Funding - Acrivon Therapeutics (Inst); ALX Oncology (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Gilead Sciences